4//SEC Filing
Oliviero James F III 4
Accession 0001104659-24-076442
CIK 0001651407other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 8:01 PM ET
Size
7.5 KB
Accession
0001104659-24-076442
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Sale
COMMON STOCK
2024-06-26$2.05/sh−24,610$50,450→ 1,977,170 total - Gift
COMMON STOCK
2024-06-26−37,890→ 1,939,280 total
Footnotes (4)
- [F1]In connection with the vesting of 62,500 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.05 to $2.0504. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares of restricted common stock, which vest over various time periods.
- [F4]On June 26, 2024, 37,890 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001434718
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 8:01 PM ET
- Size
- 7.5 KB